NDC 12 Timeline: What's Changing and How To Prepare

The move to a 12-digit National Drug Code runs on a fixed ten-year clock. Here is every date in FDA's final rule, what changes on each one, and the decisions that belong in each phase.

The short answer: FDA's 12-digit NDC rule takes effect on March 7, 2033. Until then, FDA keeps assigning 10-digit NDCs. On March 7, 2033, FDA starts assigning 12-digit NDCs and converts every existing 10-digit NDC to the new format. A three-year labeling transition follows, running to March 6, 2036. After that, drugs labeled with a 10-digit NDC may be subject to regulatory action.

All of these dates come from FDA's final rule, Revising the National Drug Code Format and Drug Label Barcode Requirements, published March 5, 2026. For what the rule changes in the code itself, see NDC 12: What the FDA's 12-Digit NDC Rule Actually Changes.

‍

Phase 1 (March 2026 to March 2033): Why is the preparation period shorter than it looks?

Nothing changes on the label yet. FDA keeps assigning 10-digit NDCs in the 4-4-2, 5-3-2 and 5-4-1 formats until March 6, 2033, and expects manufacturers, distributors, repackagers, pharmacies, providers and payors to use the time to get their systems, processes and labeling ready.

FDA calls the conversion itself a ministerial change: the same NDC in a different format, as the NDC Coordination and Implementation Forum's FAQ puts it. For registration and listing, that is accurate. It is also the most misleading true sentence in this transition. Outside FDA, that ministerial change becomes packaging artwork, barcode decisions, EDI work and an audit of every system that stores or derives an NDC, at every manufacturer, distributor, pharmacy, payer and software vendor in the supply chain.

Seven years shrinks quickly once you count label artwork cycles, ERP upgrade windows and trading partners who must change on the same day you do. The real risk is not the deadline. It is that NDC 12 never wins a budget line, because no single year is the one where it becomes urgent. Organizations that default to "next year" reach 2031 with nothing decided and only expensive options left.

That is roughly where the industry is today. At LSPedia's 2026 Logistics Forum, the NDC 12 readiness panel said companies are assessing and very few are implementing. One panelist summed up the first task: get your team together and find every place your company uses the NDC.

‍

What should you fund in 2027?

Five line items. None is an implementation. All are cheap now and expensive later.

1. One named owner. NDC 12 crosses regulatory, IT, packaging, quality and commercial. When everyone is responsible, nobody is. Give it to one person senior enough to convene all five.

2. An NDC inventory. Find every place the NDC is stored, derived, transmitted, printed or reported: item masters and NDC-to-GTIN mappings, ERP and warehouse systems, label templates and line vision systems, EDI and DSCSA EPCIS data, chargeback and returns files, and government and payer submissions. Include systems you don't own; they take longest to change. Every one of them will need to accept both 10- and 12-digit NDCs from March 7, 2033, because both formats will be in the market for three years.

3. A GTIN parsing audit. A 12-digit NDC does not fit inside a GTIN-14. It moves to GS1 Application Identifier (AI) 715, and the NDC can no longer be read out of the GTIN. Any system that derives the NDC that way will keep running after 2033 and quietly return the wrong answer. A rejected transaction tells you where to fix. A silent mismatch surfaces later as a wrong product match, a failed claim or a recall that can't be traced cleanly.

4. A packaging plan by SKU. Packaging has the longest lead times: artwork, regulatory review of labeling changes and line validation all take months per SKU. For any product that will still be on shelves after March 2033, confirm the longer human-readable NDC and a larger 2D DataMatrix still fit the label, and that printers, vision systems and scanners can validate the new data and skip application identifiers they don't recognize.

5. An EDI and vendor roadmap. The NDC appears in nearly every healthcare EDI transaction, and new 12-digit qualifiers must be added to the X12 and GS1 standards before anyone can update their own guidelines, as HDA has noted. That sequencing is outside your control, so scope the program now. Then put NDC 12 readiness on the agenda for every chargeback, 3PL, WMS, pharmacy and traceability vendor whose contract renews. A renewal is a better place to learn a partner has no plan than an escalation.

Distributors and dispensers face the same list from the other side: map every system and EDI document that carries an NDC, and ask both suppliers and software vendors for dates.

‍

What should you not do yet?

Don't build to a final spec. The standards your EDI and barcode changes depend on are still being written. Scoping is the deliverable for now.

Don't rip out working systems. The goal is format tolerance, meaning systems that accept 10, 11 and 12 digits. That is usually a change to what you have, not a replacement.

Don't wait for full clarity. You can inventory where your NDCs live without knowing what any other agency decides.

‍

Phase 2 (March 7, 2033): What changes on the effective date?

On March 7, 2033, the 12-digit NDC becomes the only format FDA assigns. Four things happen that day:

1. New NDCs are assigned in the 6-4-2 format: a six-digit labeler code, four-digit product code and two-digit package code.
2. Every existing 10-digit NDC is converted by adding leading zeros to each segment as needed.
3. FDA updates all drug listing files automatically. You update listings once your labeling carries the new NDC.
4. One 2D DataMatrix can satisfy both the NDC barcode and DSCSA product identifier requirements, carrying the NDC in AI 715 alongside serial number, lot and expiration date.

The rule covers FDA-assigned NDCs for human drugs, including biologics, and animal drugs. It does not touch NDC formats owned by others. The 11-digit NDC in HIPAA transactions is not an FDA regulation, so FDA cannot change it, and the same is true of DEA reporting, CBP filings and VA systems. Each runs on its own rulemaking schedule. That uncertainty is a reason to finish your own assessment early, not to wait: the organizations best placed to absorb a late-arriving rule will be the ones that already know where their NDCs live.

‍

Phase 3 (March 2033 to March 2036): How does the labeling transition work?

For three years, FDA does not intend to object to 10-digit NDCs remaining on drug labels, so companies can finish label updates and use up old stock. That is enforcement discretion, not a second deadline. The rule expects labeling with the 12-digit NDC to start as soon as possible.

From March 7, 2036, drugs labeled with a 10-digit NDC may be subject to regulatory action. Size print runs so 10-digit label stock runs out well before then.

‍

Will the NDC 12 deadline be extended?

FDA has not announced any extension, and the dates are written into the final rule. Planning around a delay is a risk, not a strategy.

The pressure behind the change is structural: FDA is running out of labeler codes in the current format, and the 12-digit format is what creates room for new ones. Unlike DSCSA, which phased in by trading partner type, NDC 12 has no phase-in. Every manufacturer, distributor, pharmacy, payor and system changes on the same date.

‍

The quiet version of 2033

There are two ways to arrive at March 7, 2033. In one, it is a deadline you are racing. In the other, it is an ordinary Monday.

The difference is not effort in 2032. It is whether NDC 12 became a line item, with an owner and a number, in the years when it still looked far away. 2027 is one of those years.

LSPedia works with manufacturers, distributors and dispensers on the data standards behind DSCSA, and NDC 12 runs through the same systems. LSPedia customers can use OneData to build their NDC inventory from master data. Talk to our team about mapping your NDC touchpoints.

‍